(Q77495539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

main subject

essential hypertension

1 reference

Wallis EJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Ramsay LE

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Hettiarachchi J

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

439-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

Atrial and brain natriuretic peptides: secretion during exercise in patients with essential hypertension and modulation by acute angiotensin-converting enzyme inhibition

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Antihypertensive and hypotensive effects of atrial natriuretic factor in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Effects of atrial natriuretic factor infusion on plasma prorenin levels in hypertensive males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Effects of low dose infusion of atrial natriuretic factor on acute inhibition of angiotensin converting enzyme in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990075-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(98)90075-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797801%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference